The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Discordance rate of PD-L1 expression between primary and metastatic lesions in urothelial carcinoma (UC).
 
Earle Frederick Burgess
Stock and Other Ownership Interests - Becton Dickinson; Calithera Biosciences; Exelixis; Gilead Sciences; Ignyta; Johnson & Johnson; McKesson; Medtronic
Consulting or Advisory Role - Bayer; Janssen; Pfizer; Roche/Genentech
Speakers' Bureau - Exelixis; Roche/Genentech
Research Funding - Astellas Pharma; Pfizer
Travel, Accommodations, Expenses - Exelixis; Pfizer; Roche/Genentech
 
Caroline Naso
No Relationships to Disclose
 
Shannon Doherty
No Relationships to Disclose
 
Renato Guerrieri
No Relationships to Disclose
 
Chad Livasy
Consulting or Advisory Role - Genomic Health
 
Aaron Hartman
No Relationships to Disclose
 
Myra M. Robinson
No Relationships to Disclose
 
James Thomas Symanowski
Consulting or Advisory Role - Endocyte (Inst); Lilly; Ra Pharma (Inst)
Research Funding - Bayer (Inst); Celgene (Inst); Novocure (Inst); Pfizer (Inst)
 
Claud Grigg
No Relationships to Disclose
 
David L. Graham
Employment - Medscape
Speakers' Bureau - Biopep Solution
 
Kwabena Osei-Boateng
No Relationships to Disclose
 
Stephen Boyd Riggs
Stock and Other Ownership Interests - Exelixis
Consulting or Advisory Role - AstraZeneca
 
Peter Clark
No Relationships to Disclose
 
Derek Raghavan
Consulting or Advisory Role - Caris Life Sciences (Inst); Gerson Lehrman Group